Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys.
Vision Impairment and Blindness Prevalence in the United States: Variability of Vision Health Responses across Multiple National Surveys.
复制标题
DOI：
10.1016/j.ophtha.2020.06.064
复制
发表时间：
2021-01
期刊：
影响因子：
13.7
通讯作者：
Lundeen EA
中科院分区：
文献类型：
--
作者：
Rein DB;Lamuda PA;Wittenborn JS;Okeke N;Davidson CE;Swenor BK;Saaddine J;Lundeen EA
通过比较国家调查中测量的自我报告和检查评估的视力损害（VI）和失明的患病率，支持调查验证工作。横截面比较。2016年美国社区调查，2016年行为风险因素监测系统，2016年全国健康访谈调查，2005-2008年全国健康和营养检查调查（NHANES）和2016年全国儿童健康调查的参与者。我们使用Clopper-Pearson方法估计了每个调查指标和年龄组的VI和失明患病率以及置信区间。我们使用逆方差加权来估计各年龄组指标的集中趋势，将趋势线拟合到年龄组估计值，并使用趋势线方程来估计2016年美国VI和失明人数。我们将自我报告的估计值与NHANES对VI和失明的身体评估进行了比较。VI和失明患病率估计值的变异性。自我报告估计的失明率在65岁以下的人群中为0.1%至5.6%，在65岁或以上的人群中为0.6%至16.6%。对于65岁以下的人群，VI的估计值在1.6%至24.8%之间，对于65岁或以上的人群，VI的估计值在2.2%至26.6%之间。对于总结的调查结果和NHANES身体评估，VI的患病率随年龄组的增加而显着增加。失明患病率随年龄组的增加而显着增加，但没有NHANES体检总结调查的答复。基于对所有年龄段的NHANES体检数据的外推，我们估计在2016年，美国有2340万人（7.2%）患有VI或失明，矫正前视力较好的眼睛的视力评估为20/40或更差。根据加权的自我报告调查，我们估计有2480万人（7.7%）患有VI或失明。从国家调查措施中获得的VI和失明的患病率在调查和年龄组之间差异很大。需要进一步的研究来验证VI和失明的调查自我报告措施的能力，以复制通过眼科健康专业人员检查获得的结果。
To support survey validation efforts by comparing prevalence rates of self-reported and examination evaluated presenting visual impairment (VI) and blindness measured across national surveys. Cross-sectional comparison. Participants in the 2016 American Community Survey, the 2016 Behavioral Risk Factor Surveillance System, the 2016 National Health Interview Survey, the 2005–2008 National Health and Nutrition Examination Survey (NHANES), and the 2016 National Survey of Children’s Health. We estimated VI and blindness prevalence rates and confidence intervals for each survey measure and age group using the Clopper-Pearson method. We used inverse variance weighting to estimate the central tendency across measures by age-group, fitted trend lines to age-group estimates, and used the trend-line equations to estimate the number of United States persons with VI and blindness in 2016. We compared self-report estimates with those from NHANES physical evaluations of presenting VI and blindness. Variability of prevalence estimates of VI and blindness. Self-report estimates of blindness varied between 0.1% and 5.6% for those younger than 65 years and from 0.6% to 16.6% for those 65 or older. Estimates of VI varied between 1.6% and 24.8% for those younger than 65 years and between 2.2% and 26.6% for those 65 years or older. For summarized survey results and NHANES physical evaluation, prevalence rates for VI increased significantly with increasing age group. Blindness prevalence increased significantly with increasing age group for summarized survey responses but not for NHANES physical examination. Based on extrapolations of NHANES physical examination data to all ages, we estimated that in 2016, 23.4 million persons in the United States (7.2%) had VI or blindness, an evaluated presenting visual acuity of 20/40 or worse in the better-seeing eye before correction. Based on weighted self-reported surveys, we estimated that 24.8 million persons (7.7%) had presenting VI or blindness. Prevalence rates of VI and blindness obtained from national survey measures varied widely across surveys and age groups. Additional research is needed to validate the ability of survey self-report measures of VI and blindness to replicate results obtained through examination by an eye health professional.
登录
查看更多内容
影响因子：
4.2
作者：
Crews, John E.;Chou, Chiu-Fang;Saaddine, Jinan B.
通讯作者：
Saaddine, Jinan B.
影响因子：
--
作者：
Zhang, Xinzhi;Gregg, Edward W.;Saaddine, Jinan B.
通讯作者：
Saaddine, Jinan B.
影响因子：
4.2
作者：
Lee PP;West SK;Block SS;Clayton J;Cotch MF;Flynn C;Geiss LS;Klein R;Olsen TW;Owsley C;Primo SA;Rubin GS;Ryskulova A;Sharma S;Friedman DS;Zhang X;Crews JE;Saaddine JB
通讯作者：
Saaddine JB
影响因子：
12.7
作者：
Ryskulova, Asel;Turczyn, Kathleen;Janiszewski, Rosemary
通讯作者：
Janiszewski, Rosemary
影响因子：
120.7
作者：
Ko, Fang;Vitale, Susan;Chou, Chiu-Fang;Cotch, Mary Frances;Saaddine, Jinan;Friedman, David S.
通讯作者：
Friedman, David S.